# Management of Abdominal Pain in Acute Gastroenteritis Patients With Hyoscine Butylbromide

> **NCT04682860** · PHASE4 · COMPLETED · sponsor: **Ankara City Hospital Bilkent** · enrollment: 50 (actual)

## Conditions studied

- Acute Gastroenteritis
- Abdominal Pain

## Interventions

- **DRUG:** Hyoscine N Butylbromide
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04682860
- **Lead sponsor:** Ankara City Hospital Bilkent
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-09-08
- **Primary completion:** 2021-12-03
- **Final completion:** 2022-01-03
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2022-01-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04682860

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04682860, "Management of Abdominal Pain in Acute Gastroenteritis Patients With Hyoscine Butylbromide". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04682860. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*